Tumor Mutational Burden and COVID-19: A Pathologist’s Perspective

Episode
40
Soundcloud
Share

The latest episode of Lung Cancer Considered focuses on a recent publication in IASLC's Journal of Thoracic Oncology that features new guidelines on Tumor Mutational Burden as well as the effects of COVID-19. This episode features a conversation between host Dr. Marty Edelman; Dr. Lynette Scholl an associate professor of Pathology at Harvard Medical School and an associate pathologist, Pathology at Brigham And Women's Hospital; and Dr. John Longshore director of Molecular Pathology at Carolinas Pathology Group, Atrium Health, Carolinas HealthCare System.

Guest
Lynette Sholl
Dr. Lynette Sholl

MD

Associate Professor of Pathology and Associate Pathologist
Brigham and Women's Hospital, Harvard Medical School

Other Podcast

Seminal Trials: iPass Study for EGFR NSCLC
Episode
142
Lung Cancer in Brazil
Episode
141
Patient Advocacy Groups Podcast
Episode
140
Radon Podcast
Episode
139